{"id":"W4200128746","doi":"10.1038/s41591-021-01579-0","title":"Avelumab maintenance in advanced urothelial carcinoma: biomarker analysis of the phase 3 JAVELIN Bladder 100 trial","year":2021,"lang":"en","type":"article","venue":"Nature Medicine","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Merck KGaA; Pfizer","keywords":"Javelin; Avelumab; Urothelial carcinoma; Metastatic Urothelial Carcinoma; Biomarker; Medicine; Bladder cancer; Oncology; Carcinoma; Urothelial cancer; Internal medicine; Urology; Immunotherapy; Cancer; Chemistry; Nivolumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003421978,0.0002884583,0.001038086,0.0003921814,0.00005521566,0.000004918397,0.0001969498,0.000327809,0.001316943],"category_scores_gemma":[0.0008226013,0.0001685929,0.0003782787,0.002919184,0.0002365009,0.00004811877,0.00006243129,0.00072387,0.00000474692],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001826555,"about_ca_system_score_gemma":0.0005360441,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002426034,"about_ca_topic_score_gemma":0.0004137478,"domain_scores_codex":[0.9975337,0.0001541327,0.0006623305,0.0005307599,0.0007523122,0.0003667711],"domain_scores_gemma":[0.9983537,0.0001487605,0.0002035864,0.0008032921,0.0003476224,0.000143049],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.3292425,0.01334431,0.1505732,0.0007420399,0.01872533,0.004406215,0.007936079,0.0001008946,0.2890551,0.001876186,0.03046541,0.1535327],"study_design_scores_gemma":[0.5690553,0.002599648,0.3425283,0.0007657182,0.01110024,0.0001303098,0.001050462,0.001126937,0.04576463,0.0002818045,0.02508577,0.0005108732],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9777832,0.006127729,0.00009096495,0.007499398,0.0014493,0.001029186,0.0001256206,0.00002605527,0.005868514],"genre_scores_gemma":[0.9938148,0.0001282883,0.0001668461,0.002458427,0.0004230007,0.0000533394,0.0001213377,0.00003101951,0.002802974],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2432905,"threshold_uncertainty_score":0.999596,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02005866707782456,"score_gpt":0.3429450405668656,"score_spread":0.3228863734890411,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}